Select Page
nonconforming materials report

 Top 483 Observations in 2021

Every year, PathWise complies the top FDA 483 observations from their inspection observations to view trends and patterns. In a year with fewer inspections due to pandemic disruptions, there were still notable trends. Download our data, to see what all the common violations are in your area, so you know where to start improvement projects in your quality system!

Download your FREE White Paper!


* These fields are required.

FOLLOW PATHWISE!

CHECK OUT OTHER PATHWISE WHITE PAPERS!

Role-Based Training in Investigations and CAPA: Supporting Quality in Medical Device and Pharmaceutical Manufacturing

In the highly regulated environments of medical device and pharmaceutical manufacturing, ensuring...

White Paper: What’s the Right Number of CAPAs?

Spoiler alert- it’s not an exact number, and that number isn’t zero. The right number of CAPAs...

Key Performance Indicators for Life Science

Key Performance Indicators for Life Science The number of possible KPIs is endless. It all depends...

Free Download! Top 483 Observations from 2022

Top FDA 483 Warning Letter Observations from 2019 for Medical Device, Drugs, and Biologics Every...